DRUG · COUNSELLING NOTES
Nivolumab / Relatlimab
Opdualag, RELATLIMAB / NIVOLUMAB
Updated
New prescription
indication: _____. IV by healthcare professional; report diarrhea, rash; warned on allergies; AEs: immune colitis/hepatitis/pneumonitis, fatigue, rash; non-pharm: sun protection, activity pacing.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV by healthcare professional; report diarrhea, rash; warned on allergies; AEs: immune colitis/hepatitis/pneumonitis, fatigue, rash; non-pharm: sun protection, activity pacing.